LACTB has been reported to be a tumor suppressor (17), and decreased expression of LACTB has been observed in various cancers, including breast cancer (17), colon cancer (18), glioma (19), ovarian cancer (20) and liver cancer (21). Here, LACTB is linked to glioma.